HRT Financial’s AVEO Pharmaceuticals AVEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-57,975
Closed -$866K – 3620
2022
Q4
$866K Buy
+57,975
New +$803K 0.01% 1052
2021
Q3
– Sell
-41,428
Closed -$273K – 4103
2021
Q2
$273K Buy
+41,428
New +$286K ﹤0.01% 2206
2018
Q3
– Sell
-2,048
Closed -$46K – 535
2018
Q2
$46K Buy
+2,048
New +$48.6K 0.02% 243

HRT Financial's AVEO Position: Q1 2023 in Review

HRT Financial sold out of AVEO Pharmaceuticals (AVEO) in Q1 2023, closing a stake of 57,975 shares — an estimated $866K sold.

HRT Financial first reported a position in AVEO in Q2 2018 and held it in 3 quarters. The position peaked at $866K in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

  • HRT Financial reported no remaining AVEO Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • HRT Financial sold 57,975 AVEO Pharmaceuticals shares in Q1 2023, an estimated $866K.
  • HRT Financial first reported a position in AVEO Pharmaceuticals in Q2 2018 and held it in 3 quarters.
  • HRT Financial's AVEO Pharmaceuticals position peaked at $866K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals as of Q1 2023.

Based on HRT Financial's 13F filing for Q1 2023, filed 12 May 2023.